期刊文献+

银杏叶提取物对豚鼠卡那霉素耳毒性早期干预作用的效果评价

Evaluation of the Early Intervention with EGB761 on Kanamycin-induced Deafness in Guinea Pig
暂未订购
导出
摘要 目的建立豚鼠卡那霉素耳毒性聋模型,观察银杏叶提取物对卡那霉素耳毒性聋的早期干预作用。方法将豚鼠随机分成正常对照组(不做任何处理)、卡那霉素组(连续肌肉注射卡那霉素7天)、银杏叶提取物干预组(肌注卡那霉素的同时,于不同时间同时注射银杏叶提取物金钠多)。测定各组动物听性脑干反应(ABR),通过比较各组豚鼠波Ⅲ阈值、100dB SPL声刺激时波Ⅲ潜伏期和峰值差异,评价银杏叶提取物对早期卡那霉素耳毒性的干预作用。结果卡那霉素组ABR波Ⅲ阈值高于正常对照组,差异有统计学意义(P<0.05),说明本实验中卡那霉素成功致聋;卡那霉素组和银杏叶提取物干预各组之间的波Ⅲ阈值差异无统计学意义(P>0.05)。结论卡那霉素耳毒性聋的早期使用银杏叶提取物可能没有任何保护和治疗作用,是否加重耳毒性作用还有待进一步研究。 Objective To establish an experimental kanamycin- induced deafness model for the study of EGB761 as the early intervention for kanamycin - induced deafness in guinea pig. Methods The guinea pigs were injected with kanamycin. At the same time, the EGB761 - intervene groups were set up. After the experiment , the auditory function was measured with ABR. Results The animal model of kanamycin- induced deafness was successfirUy established. The auditory function of the EGB761 - intervene group was not worse or better than that of kanamycin group. Conclusion EGB761 shows neither protection nor treatment effect as the early intervention to kanamycin - induced deafness, on the contrary, this can expose guinea pigs to greater kanamycin ototoxicity.
出处 《听力学及言语疾病杂志》 CAS CSCD 2006年第5期354-356,共3页 Journal of Audiology and Speech Pathology
关键词 卡那霉素 耳聋 银杏叶提取物 Kanamycin Hearing loss EGB761
  • 相关文献

参考文献5

二级参考文献29

  • 1耿秀芳,孟祥国,栾美英,李乃敏,孙风祥.银杏叶黄酮扩血管机理的探讨[J].中医药研究,1996,12(1):55-56. 被引量:32
  • 2陈修.银杏叶提出物的心脑血管药理研究进展与启示[J].中国中西医结合杂志,1996,16(7):387-389. 被引量:79
  • 3孔维佳,任田英.硝普钠耳毒作用的内耳靶组织[J].耳鼻咽喉(头颈外科),1996,3(3):176-180. 被引量:6
  • 4Didier A, Droy-lefaix M T, Aurousseau C, et al.Effects of ginkgo biloba extract (Egb 761) on cochlear vasculature in the guinea pig: morphometric measurements and laser doppler flowmetry. Eur Arch Otorhinolaryngol, 1996,253: 25-30.
  • 5Carlisle L, Aberdeen J, Forge A,et al. Neural basis for regulation of cochlear blood flow: peptidergic and adrenergic innervation of the spiral modiolar artery of the guinea pig. Hear Res,1990,43:107-114.
  • 6Nakashima T,Nuttall A L,Miller J M. Effects of vasodilating agents on cochlear blood flow in mice. Hear Res, 1994,80:241-246.
  • 7Ravi R, Somani SM, Rabak LP, et al. Mechanism of cisplaitn ototoxicity: antioxidant system. Pharmacol Toxicol, 1995, 76, 386-394.
  • 8Rabak LP, Husain K, Whitworth C, et al. Dose dependent protection by lipoic acide against cisplatin-induced ototoxicity in rats, antioxidant defense system. Toxicol Sci, 1999, 47:195-202.
  • 9Rabak LP, whitworth C, Somani S, et al. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope, 1999,109 : 1740-1744.
  • 10Fleischman RW, Standnicki SW, Ethier M, et al. Ototoxicity of cis-diammindichloroplatin Ⅱ in the guinea pig. Toxicol Appl Pharmacol, 1975, 33:320-332.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部